• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
MEDICAFFAIRS |

MEDICAFFAIRS |

translating clinical research into medical practice

  • Home
  • About
    • About Us
    • Webinars
    • Network
    • Contact Us
  • Services
  • Partners
  • Clients
  • Medical News
    • thehill.com
    • flipboard.com
  • Publications
    • GoogleScholar
    • ResearchGate
  • Facebook
  • Linkedin
  • Twitter
  • YouTube

LABORATORY-DEVELOPED TESTS

FDA hold on guidance for laboratory developed tests is a wise action

FDA hold on guidance for laboratory developed tests is a wise action

November 29, 2016 By MEDICAFFAIRS

On Nov. 18, the Food and Drug Administration (FDA) announced that an oversight policy regulating laboratory developed tests (LDTs) will be put on hold. The agency will reconsider this guidance in discussions with the new administration, Congress and stakeholders. This is good news for those

Primary Sidebar

Our medical news, blogs and webinars keep our clients up to date.

Search

Tags

BARACK OBAMA CANCER CANCER CARE ACT CANCER MEDICINE CANCER RESEARCH FDA HEALTHCARE JOE BIDEN LABORATORY-DEVELOPED TESTS SCIENCE

Recent Posts

  • Why we need a Cancer Care Act
  • Beyond the moonshot: Achieving universal cancer care
  • FDA hold on guidance for laboratory developed tests is a wise action
  • This is personal: Less chemotherapy for breast cancer

Follow Us on Social Media:

  • Facebook
  • Linkedin
  • Twitter
  • YouTube

Follow me on Twitter

Tweets by @medicaffairs

MEDICAFFAIRS supports pharmaceutical, medical devices and diagnostics companies, specializing in companion diagnostics and precision medicine.

Copyright © 2018 · MEDICAFFAIRS · Design by Standoutbooks · Privacy